Article · 22 Mar 2024
Conference abstractPublished 24 Oct 2018
Microfluidics: An advanced platform for pharmaceutical protein formulation
Harvard University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
One of the therapies which hold enormous potential for treating many terminal diseases includes protein-based therapies. Yet due to scarcity in development of universal technological approaches that develops protein formulations with targeted attributes blocks the clinical translation of these advanced therapies. The current study emphasized development of protein formulation with using droplet-based microfluidic technology which characterizes size, internal morphology, protein release profile and encapsulation efficiency.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 24 Dec 2014
Utilisation of Moringa oleifera Seed Protein in Pharmaceutical Formulation.
Editorial · 28 Nov 2025
Advancements in Pharmaceutical Formulation and Drug Delivery Strategies
Editorial · 28 Nov 2025
Advancing Pharmaceutical Formulation and Drug Delivery Strategies
Editorial · 28 Nov 2025
Advanced Pharmaceutical Formulation and Drug Delivery Strategies
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Sabiruddin Mirza”
